CF
PRCT icon

Corebridge Financial’s Procept Biorobotics PRCT Stock Holding History

Corebridge Financial’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,828
Closed -$1.27M – 2082
2025
Q1 		$1.27M Sell
21,828
-324
-1% -$22.1K 0.01% 1161
2024
Q4 		$1.78M Sell
22,152
-496
-2% -$42.4K 0.01% 1067
2024
Q3 		$1.81M Sell
22,648
-139
-0.6% -$9.88K 0.01% 1083
2024
Q2 		$1.39M Buy
+22,787
New +$1.36M 0.01% 1163

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Corebridge Financial's PRCT Position: Q2 2025 in Review

Corebridge Financial sold out of Procept Biorobotics (PRCT) in Q2 2025, closing a stake of 21,828 shares — an estimated $1.27M sold.

Corebridge Financial first reported a position in PRCT in Q2 2024 and held it in 4 quarters. The position peaked at $1.81M in Q3 2024. 271 funds tracked by Wall St. Rank hold PRCT as of Q2 2025.

  • Corebridge Financial reported no remaining Procept Biorobotics position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 21,828 Procept Biorobotics shares in Q2 2025, an estimated $1.27M.
  • Corebridge Financial first reported a position in Procept Biorobotics in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Procept Biorobotics position peaked at $1.81M in Q3 2024.
  • 271 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.